Does Kaiser Permanente Pay for GLP-1 Medications? (2026)

Kaiser Permanente covers GLP-1 medications only in limited cases; prior authorization is required, and members who are approved typically pay $10-$50 a month.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Where Kaiser Permanente stands[1]
Limited
12,700,000 members · Prior authorization needed[1]
Limited

If your question is only about Wegovy and Zepbound, read does Kaiser cover Zepbound and Wegovy, which reads Kaiser's regional formularies and the step criteria behind them.

Where Each Medication Stands[5]

How Kaiser handles each GLP-1, and the usual copay when one is covered. Copay in USD per month.
MedicationWhat Kaiser does
Wegovy (semaglutide)Kaiser is its own plan, doctors and pharmacy, so coverage follows its regional formularies rather than a PBM. Wegovy is on the formulary in the two regions we read: the 2026 Southern California Commercial HMO list (updated 10/01/2026) carries Wegovy pens and Wegovy HD at tier 2, and the 2026 Northwest Commercial Formulary (effective 12/17/2026) carries Wegovy pens, Wegovy HD and the Wegovy pill as preferred brands with PA. In the Northwest, Wegovy for weight loss is covered only for members whose plan includes weight-loss drugs (others pay the member cash price), and the criteria ask for 3-month trials of at least two older weight-loss drugs first; separate Northwest routes cover heart-risk reduction (no diabetes, BMI >=27, age 55 to 74, a prior STEMI or Type 1 NSTEMI), severe sleep apnea and MASH. Kaiser Washington said in January 2026 that the Wegovy pill is generally not covered on its commercial plans and that Ozempic is its semaglutide for members with a weight-loss rider. On Kaiser's FEHB plans, GLP-1 drugs and oral weight-loss drugs cost 50% coinsurance of the plan allowance, under Kaiser's prior authorization guidelines.
Ozempic (semaglutide)Covered for type 2 diabetes through Kaiser pharmacy: Ozempic is on the 2026 Southern California HMO formulary and is a preferred brand with PA in the Northwest. Kaiser Washington uses Ozempic as its semaglutide for diabetes, MASH, sleep apnea and members with a weight-loss rider, with prior authorization and step criteria.
Zepbound (tirzepatide)Limited. Neither the Southern California HMO list nor the Northwest commercial list carries Zepbound, though Southern California covers a non-formulary drug when a Kaiser doctor finds it medically necessary. Northwest criteria (effective 12/17/2026) cover Zepbound as non-formulary only for members whose plan covers weight-loss drugs, after 3-month trials of at least two older weight-loss drugs and then at least 6 months of semaglutide followed by a bariatric medicine chart review, approved 12 months at a time; a sleep apnea route requires severe OSA (AHI 30 or more) and the same steps. On Kaiser's FEHB plans, GLP-1 drugs cost 50% coinsurance of the plan allowance.
Mounjaro (tirzepatide)Not on the formulary in Southern California or the Northwest. Northwest criteria (effective 03/05/2026) cover it as a non-formulary drug for type 2 diabetes only after metformin, a sulfonylurea, pioglitazone and an SGLT2 inhibitor, at least 3 months on maximum-dose liraglutide without reaching an HbA1c under 7%, and at least 3 months on maximum-dose semaglutide (or documented intolerance).
Copay when it is covered$10-$50 / month

What a GLP-1 costs a Kaiser Permanente member

At Kaiser Permanente's typical copay of $10-$50 a month, a covered year of a GLP-1 costs $120 to $600. That is $3,588 to $4,068 less than a year of Wegovy bought for cash from NovoCare ($4,188), and Zepbound's LillyDirect price of $299 to $449 a month is further above it still.

The cheapest compounded option, WellMedRx at $49/mo ($588 a year), lands inside the Kaiser range, and 1 seller charge no more than the $50 top of it, so for a member facing that copay a denial costs less than it sounds.

When Kaiser covers the drug, a manufacturer savings card can bring a Wegovy or Zepbound fill down to $25, with each maker paying at most $100 a month.

Employers whose plans run through Kaiser

Your employer decides much of this. Among the employers in our coverage checker, 1 use Kaiser to run medical or pharmacy benefits: JPMorgan Chase. JPMorgan Chase's Wegovy position, for example: Covered with $50/month copay (Medical Plan Option 1) or $100/month (Option 2) via CVS Caremark; $30 copay on the California Kaiser plan.

After a Denial from Kaiser Permanente

A Kaiser denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[3]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[4] cost far less than the brand; the cheapest sellers are listed below.

If a large employer self-funds your Kaiser plan, ERISA rather than state insurance law applies and the employer decides whether anti-obesity drugs are covered[2]; the Summary Plan Description says which.

Where to go if Kaiser Permanente says no

The 8 cheapest cash-pay compounded GLP-1s

Cheapest cash-pay compounded GLP-1 sellers
#SellerMonthly priceVisit
1WellMedRx
Compounded semaglutide
$49/moVisit
2Collective
Compounded semaglutide
$59/moVisit
3RenewlyRX
Compounded semaglutide
$68/moReview
4Lean Meds
Compounded semaglutide
$79/moReview
5Tryozi
Compounded semaglutide
$79/moReview
6Embody
Compounded semaglutide
$79/moVisit
7NextMeds
Compounded semaglutide
$79/moReview
8CoreAge Rx
Compounded semaglutide
$79/moVisit

Top-rated sellers that bill insurance

23 sellers say they accept insurance. Confirm with the seller that it bills Kaiser before you book.

Sellers that bill insurance
#SellerCash priceVisit
1NovoCare Pharmacy$149/moReview
2Ivim Health$140/moVisit
3Thrivelab$175/moReview
4Spry$199/moReview
5Calibrate HealthPrice not publishedReview

Every seller and price, side by side: compare all sellers.

Our picks

Starting price per provider. Prices in USD per month; checked November 2026.
#ProviderScore
1CollectiveVisit
2EmbodyVisit
3RxSpan MDVisit
4EdenVisit
5YourEraVisit

Frequently Asked Questions

Kaiser is its own plan, doctors and pharmacy, so coverage follows its regional formularies rather than a PBM. Wegovy is on the formulary in the two regions we read: the 2026 Southern California Commercial HMO list (updated 10/01/2026) carries Wegovy pens and Wegovy HD at tier 2, and the 2026 Northwest Commercial Formulary (effective 12/17/2026) carries Wegovy pens, Wegovy HD and the Wegovy pill as preferred brands with PA. In the Northwest, Wegovy for weight loss is covered only for members whose plan includes weight-loss drugs (others pay the member cash price), and the criteria ask for 3-month trials of at least two older weight-loss drugs first; separate Northwest routes cover heart-risk reduction (no diabetes, BMI >=27, age 55 to 74, a prior STEMI or Type 1 NSTEMI), severe sleep apnea and MASH. Kaiser Washington said in January 2026 that the Wegovy pill is generally not covered on its commercial plans and that Ozempic is its semaglutide for members with a weight-loss rider. On Kaiser's FEHB plans, GLP-1 drugs and oral weight-loss drugs cost 50% coinsurance of the plan allowance, under Kaiser's prior authorization guidelines.
Covered for type 2 diabetes through Kaiser pharmacy: Ozempic is on the 2026 Southern California HMO formulary and is a preferred brand with PA in the Northwest. Kaiser Washington uses Ozempic as its semaglutide for diabetes, MASH, sleep apnea and members with a weight-loss rider, with prior authorization and step criteria.
Limited. Neither the Southern California HMO list nor the Northwest commercial list carries Zepbound, though Southern California covers a non-formulary drug when a Kaiser doctor finds it medically necessary. Northwest criteria (effective 12/17/2026) cover Zepbound as non-formulary only for members whose plan covers weight-loss drugs, after 3-month trials of at least two older weight-loss drugs and then at least 6 months of semaglutide followed by a bariatric medicine chart review, approved 12 months at a time; a sleep apnea route requires severe OSA (AHI 30 or more) and the same steps. On Kaiser's FEHB plans, GLP-1 drugs cost 50% coinsurance of the plan allowance.
Not on the formulary in Southern California or the Northwest. Northwest criteria (effective 03/05/2026) cover it as a non-formulary drug for type 2 diabetes only after metformin, a sulfonylurea, pioglitazone and an SGLT2 inhibitor, at least 3 months on maximum-dose liraglutide without reaching an HbA1c under 7%, and at least 3 months on maximum-dose semaglutide (or documented intolerance).
Members who are approved typically pay $10-$50 a month, which is $120 to $600 over a year. A manufacturer savings card can lower that further when the plan covers the drug.
Appeal first: ask Kaiser for the written denial and the criteria it applied, and have your prescriber answer them in a letter of medical necessity. If the appeal fails, the cheapest cash route is compounded semaglutide or tirzepatide, from WellMedRx at $49/mo or Collective at $59/mo. 23 sellers say they bill insurance. A compounded drug is not FDA-approved as a finished product.

Glossary

The words sellers use, defined. Tap any term.

Sources & methodology — as of November 2026
  1. 1.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
  2. 2.U.S. Department of Labor — ERISA and Employer Health Plans— U.S. Department of Labor, Employee Benefits Security Administration.
  3. 3.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.